Osteoporosis and thyrotropin-suppressive therapy: reduced effectiveness of alendronate.

@article{Panico2009OsteoporosisAT,
  title={Osteoporosis and thyrotropin-suppressive therapy: reduced effectiveness of alendronate.},
  author={Annalisa Panico and Gelsy Arianna Lupoli and Francesco Fonderico and Francesca Marciello and Addolorata Martinelli and Roberta Assante and Giovanni Lupoli},
  journal={Thyroid : official journal of the American Thyroid Association},
  year={2009},
  volume={19 5},
  pages={437-42}
}
BACKGROUND Many reports of the effect of exogenous thyroxine therapy on bone mineral density (BMD) show a relationship between excess thyroid hormone administration and osteoporosis. The aim of this study was to evaluate the effect of antibone resorptive agents, in particular alendronate (ALN) on BMD in postmenopausal osteoporotic women with thyroid… CONTINUE READING